The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

Overview of Market Growth

• The automation in biopharma industry market has experienced significant growth.
• Expected growth from $1.94 billion in 2023 to $2.06 billion in 2024 at a CAGR of 6.4%.
• Forecasted to reach $2.66 billion in 2028 with a CAGR of 6.6%.

Factors Driving Growth

• Increased complexity in biopharmaceutical processes.
• Need for improved process efficiency.
• Growth in biologics development and manufacturing.
• Demand for quality assurance and control.
• Pressure to reduce time-to-market.

Role of Robotics in Pharmaceutical Manufacturing

• Adoption of robots in pharmaceutical manufacturing propelling market growth.
• Robots perform various tasks, enhancing productivity and precision.
• Notable growth in North American robotics market in 2021.
• Application of robotics in life sciences and pharmaceutical sectors increasing substantially.

Read More On The Automation In Biopharma Industry Market Report 2024 – https://www.thebusinessresearchcompany.com/report/automation-in-biopharma-industry-global-market-report

Key Players in the Market

• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Danaher Corporation.
• ABB Ltd.
• Siemens Healthineers AG.
• Emerson Electric Co.
• And more.

Innovative Technological Strides

• Technological advancements key trend in the market.
• Companies focused on developing advanced product technologies.
• Example: PerkinElmer Inc.’s Cellaca PLX Image Cytometry System.
• Simplifies cell and gene therapy research and manufacturing.

Acquisitions and Expansions

• Bruker Corporation’s acquisition of Optimal Industrial Automation Limited in April 2022.
• Strengthens Bruker as a software and solutions provider.
• Optimal Industrial Automation Limited offers pharmaceutical and biopharmaceutical automation solutions.

Market Segmentation

1. By Technology
   • Automation Technology
   • Digitization Technology
2. By Component
   • Automation Hardware
   • Automation Software
   • Services Project Phase
   • Services Operation Phase
3. By Application
   • Clinical Phase
   • Drug Discovery Phase
   • Production Phase

Regional Analysis

• North America was the largest region in the automation in biopharma industry market in 2023.

Conclusion The automation in the biopharma industry is witnessing robust growth driven by technological advancements, the increasing role of robotics, and the demand for efficiency and quality in pharmaceutical manufacturing processes. With major players innovating and expanding their offerings, coupled with the rise of personalized medicine and modular bioprocessing facilities, the future of automation in biopharma promises continued evolution and expansion. As the industry moves forward, collaborations between biopharma and technology companies, alongside a focus on sustainability, are expected to shape the landscape of biopharmaceutical automation in the coming years.

Request for A Sample Of The Global Automation In Biopharma Industry Market Report:
https://www.thebusinessresearchcompany.com/sample_request?id=12704&type=smp